Philips has received 510(k) clearance from the FDA for IntelliSite Pathology Solution 5.1, a comprehensive system integrating whole-slide scanners, an image management system, and support services to transition labs from analog to digital workflows.

Philips, which entered the digital pathology market in 2017, has its solutions used in over 300 laboratories worldwide.

The digital workflow of Philips IntelliSite Pathology Solution shortens the time required for case reviews and reports and allows pathologists to work remotely, increasing efficiency by up to 21% compared to traditional workflows. This improvement helps mitigate the shortage of trained pathologists and reduce operational costs for both commercial providers and hospital pathology departments.

"Digital pathology is helping to revolutionize how we diagnose and potentially treat cancer. With the 510(k) approval, we expand our ability to help pathology laboratories transform to fully digital workflows, saving time and easing the burden on pathologists and patients,” said Martijn Hartjes, clinical informatics business leader at Philips.

Additionally, the solution's capability for remote collaboration allows pathologists to seek second opinions and leverage cloud-based AI applications, resulting in timely and precise diagnoses. Philips' open-platform approach ensures secure data sharing, facilitating clinical collaboration and medical research, which can lead to the development of new diagnostic algorithms, disease biomarkers, and treatment options.

Pathology Homepage